• DKSH agreed to acquire Thailand-based API distributor P.R. Chemicals to expand its Performance Materials pharma business.
• Target generated net sales of more than CHF 11 million in 2025, supported by a team of 27 employees.
• Deal adds more than 100 customers in Thailand, widening DKSH’s reach in healthcare-related specialty ingredients across Southeast Asia.
• DKSH will buy 100% of the business, with closing expected in Q4 2026 subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DKSH Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2388962_en) on August 27, 2026, and is solely responsible for the information contained therein.